HIVE Stock Slips As Analyst Trims Price Target

HIVE Digital Technologies Ltd stocks have been trading down by -4.83 percent amid bearish sentiment on cryptocurrency and AI-related equities.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading HIVE

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways For HIVE Traders

Keefe Bruyette trims Hive Digital’s price target from $5.00 to $4.50 and reiterates a Market Perform rating.
The firm cites overall optimism for high-performance computing colocation demand as a positive driver for Hive Digital.
Analysts highlight caution around funding risks and AI-tenant model risk as key concerns for the company.
Recent share price weakness is framed as a valuation reset tied to Hive Digital’s project pipeline rather than a structural deterioration in asset quality.

Live Update At 15:03:17 EDT: On Friday, July 31, 2026 HIVE Digital Technologies Ltd stock [NASDAQ: HIVE] is trending down by -4.83%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

HIVE Digital Technologies Ltd has been trading in a tight but choppy range, and the chart tells the story. Over the last few weeks, HIVE’s daily closes slipped from around $3.38 on 2026/07/06 to $2.855 on 2026/07/31. That’s a controlled downtrend, not a collapse, but it confirms the “valuation reset” language analysts are using.

Intraday, HIVE’s 5‑minute tape around the latest close shows a slow bleed from the $3.03 premarket area down toward the high‑$2.80s, then grinding sideways around $2.85–$2.89. That kind of action screams indecision — no aggressive buyers, but also no panic dumping. For short‑term traders, HIVE is behaving like a range‑bound, scalp‑friendly name, not a momentum rocket.

More Breaking News

Fundamentals back up the idea that this is a high‑risk, high‑reward story. HIVE generated about $213.2M in quarterly revenue, but posted a net loss of roughly $145.3M, with EBITDA at about -$143.6M. Margins are deeply negative, and return on equity is sharply below zero. On the other hand, HIVE’s balance sheet shows modest debt — long‑term borrowings and leases together are small versus $529.4M of equity — and current assets still slightly exceed current liabilities. The company is not drowning, but it is burning cash to chase future growth.

Why Traders Are Watching HIVE After The Target Cut

Keefe Bruyette’s move on HIVE Digital Technologies Ltd is subtle but important. Trimming the price target from $5.00 to $4.50 while keeping a Market Perform rating tells traders one thing clearly: expectations needed to come down, but the story is not broken.

For HIVE, that “valuation reset” matches what we see in the tape. The stock has faded from the mid‑$3s into the high‑$2s as traders reassess how much they want to pay for a high‑performance computing and AI‑linked colocation play that is still losing money. When an analyst frames that slide as pipeline‑driven, not asset‑quality driven, it says the hardware and infrastructure HIVE owns are still viewed as valuable. The question is timing and funding, not survival.

The note also zeroes in on two big risks every active trader should underline on their HIVE watchlist: funding risk and AI‑tenant model risk. HIVE needs capital to build out and fill its colocation footprint, and that usually means dilution, debt, or both when cash flow is negative. At the same time, the AI‑tenant model — essentially, which AI clients sign on, on what terms, and how sticky they are — will drive how fast revenue can scale.

Combine those uncertainties with the chart, and HIVE turns into a classic battleground name. Bulls focus on rising demand for high‑performance computing capacity. Bears focus on the red ink and execution hurdles. For day traders and swing traders, that tension can create clean breaks above $3.00 or ugly flushes under $2.80. Either way, HIVE remains a name to stalk, not blindly chase.

Conclusion

For active traders, HIVE Digital Technologies Ltd sits right in the middle of the risk curve. The analyst community is not calling HIVE a disaster — the Market Perform rating stays in place — but the price target cut to $4.50 recognizes that the near‑term path is bumpy. The stock’s slide from the mid‑$3s to the high‑$2s lines up with that message: enthusiasm has cooled, yet the fundamental thesis around HPC colocation demand is still on the table.

The financials remind everyone why HIVE trades with this kind of volatility. Strong top‑line growth, big losses, and a still‑manageable balance sheet is the classic profile of a speculative growth name. If HIVE executes on its project pipeline and lands the right AI tenants, the current pricing may eventually look cheap. If funding gets more expensive or client demand disappoints, the downside can open fast.

That is why traders in the Tim Sykes community hammer rules over predictions. As Tim likes to say, “The market doesn’t care about your opinion, only your preparation. Study the patterns, plan your trades, and always be ready to cut losses quickly.” As Tim Bohen, lead trainer with StocksToTrade says, “Success in trading is more about cutting losses quickly than finding winners.”. HIVE Digital fits that mindset perfectly — a volatile, news‑driven stock where discipline, not hope, decides who lasts. This article is for educational and research purposes only and should be used as a starting point for your own due diligence on HIVE.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!